| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |